Maxcyte (MXCT) Research & Development (2020 - 2025)
Historic Research & Development for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to $5.3 million.
- Maxcyte's Research & Development changed 0.0% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.1 million, marking a year-over-year decrease of 576.85%. This contributed to the annual value of $22.2 million for FY2024, which is 667.59% down from last year.
- As of Q3 2025, Maxcyte's Research & Development stood at $5.3 million, which was down 0.0% from $6.3 million recorded in Q2 2025.
- Maxcyte's 5-year Research & Development high stood at $6.7 million for Q1 2024, and its period low was $2.7 million during Q3 2021.
- Its 5-year average for Research & Development is $5.2 million, with a median of $5.6 million in 2024.
- Its Research & Development has fluctuated over the past 5 years, first plummeted by 3919.96% in 2021, then skyrocketed by 9385.85% in 2022.
- Quarter analysis of 5 years shows Maxcyte's Research & Development stood at $3.4 million in 2021, then surged by 69.45% to $5.7 million in 2022, then increased by 2.0% to $5.8 million in 2023, then decreased by 21.02% to $4.6 million in 2024, then grew by 15.21% to $5.3 million in 2025.
- Its Research & Development was $5.3 million in Q3 2025, compared to $6.3 million in Q2 2025 and $5.9 million in Q1 2025.